Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Other Non-Current Assets: 2023-2024

Historic Other Non-Current Assets for Silence Therapeutics (SLN) over the last 2 years, with Dec 2024 value amounting to $3.6 million.

  • Silence Therapeutics' Other Non-Current Assets fell 85.68% to $399,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $399,000, marking a year-over-year decrease of 85.68%. This contributed to the annual value of $3.6 million for FY2024, which is 1.54% down from last year.
  • As of FY2024, Silence Therapeutics' Other Non-Current Assets stood at $3.6 million, which was down 1.54% from $3.6 million recorded in FY2023.
  • Silence Therapeutics' 5-year Other Non-Current Assets high stood at $3.6 million for FY2023, and its period low was $3.6 million during FY2024.
  • In the last 2 years, Silence Therapeutics' Other Non-Current Assets had a median value of $3.6 million in 2023 and averaged $3.6 million.
  • Data for Silence Therapeutics' Other Non-Current Assets shows a maximum YoY decreased of 1.54% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Silence Therapeutics' Other Non-Current Assets stood at $3.6 million in 2023, then declined by 1.54% to $3.6 million in 2024.